David M. Spencer, Chief Scientific Officer at BELLICUM PHARMACEUTICALS, INC (BLCM), sold 22,700 shares at $20.04 ($453K) on 2016-09-21, disclosed to the SEC on 2016-09-23.
Open-market sale of $453k BLCM by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.04 | 300 | $6K | 1.3% |
| 2 | $19.68 | 10,000 | $197K | 43.4% |
| 3 | $20.19 | 6,200 | $125K | 27.6% |
| 4 | $20.19 | 6,200 | $125K | 27.6% |
| Total | $19.96 avg | 22,700 | $453K | 100% |
| Filing → |
| BLCM | SELL | 2017-07-12 | $231K | — | Filing → |
| BLCM | SELL | 2016-12-05 | $139K | — | Filing → |
| BLCM | SELL | 2016-12-05 | $100K | — | Filing → |